Table of Contents
Volume 6 | Issue 3
Publication Date: November 2004- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
138 |
Combining Targeted Agents in Lung Cancer Chandra P. Belani, Alex Adjei |
|
Researches in Brief | ||
141-142 |
Activity of Bortezomib in Advanced Non–Small-Cell Lung Cancer G. Kesava Reddy, Chandra P. Belani, Vinay K. Jain |
|
145-148 |
Emerging Molecular Biomarkers for Early Detection of Lung Cancer in Patients at High Risk Nancy Price, Vinay K. Jain, Chandra P. Belani |
|
Comprehensive Reviews | ||
149-153 |
Radiofrequency Ablation: Identification of the Ideal Patient Hiran C. Fernando, Alberto De Hoyos, Virginia Litle, Chandra P. Belani, James D. Luketich |
|
154-161 |
Therapeutic Advances in Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer Philip D. Bonomi |
|
162-169 |
Adjuvant Therapy of Resected Non–Small-Cell Lung Cancer Mark A. Socinski |
|
Original Contributions | ||
170-174 |
Clinical Benefit of Zoledronic Acid in Patients with Lung Cancer and Other Solid Tumors: Analysis Based on History of Skeletal Complications Vera Hirsh, N. Simon Tchekmedyian, Lee S. Rosen, Ming Zheng, Yong-Jiang Hei |
|
175-183 |
Prospective Randomized Phase III Trial of Etoposide/Cisplatin Versus High-Dose Epirubicin/Cisplatin in Small-Cell Lung Cancer Angel Artal-Cortés, Jose Gomez-Codina, Jose Luis Gonzalez-Larriba, Isidoro Barneto, Alfredo Carrato, Dolores Isla, Carlos Camps, Carlos Garcia-Giron, Albert Font, Alfredo Meana, Maria Lomas, Catalina Vadell, Antonio Arrivi, Carmen Alonso, Inmaculada Maestu, Joaquin Cambell, Rafael Rosell, on behalf of the Spanish Lung Cancer Group |
|
Translational Medicine | ||
184-189 |
Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer Michael Lahn, Chen Su, Shuyu Li, Marcio Chedid, Kimberly R. Hanna, Jeremy R. Graff, George E. Sandusky, Doreen Ma, Clet Niyikiza, Karen L. Sundell, William J. John, Thomas J. Giordano, David G. Beer, Blake M. Paterson, Eric Wen Su, Thomas F. Bumol |
|